Procurement Summary
Country: Slovakia
Summary: Laronidase, 100 U/ml Infusion Concentrate
Deadline: 17 Aug 2022
Posting Date: 13 Aug 2022
Other Information
Notice Type: Tender
TOT Ref.No.: 70287696
Document Ref. No.: 442400-2022
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
CPV Classification
33698300 - Peptic substances
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
DOCUMENT TYPE: Corrigendum/Additional Information (Please Refer Tender Document)
Title: Laronidase, 100 U/ml infusion concentrate
Reference Number: 84-2022
Contract Type: Supplies
Description: The medicine is used to treat patients with MPS I disease (mucopolysaccharidosis I). It is administered for the treatment of non -urological manifestations of this disease.
The medicine is a synthetic enzyme called laponidase. It can replace the natural enzyme, which is also lack of MPS
33698300 - Peptic substances
Authority Type: Body Governed by Public Law
Type of Procedure: Open procedure
Regulation: European Union, with Participation by GPA Countries
BID TYPE: Submission for All Lots
DOC TITLE: Peptic Substance
Dispatch Date: 2022-08-10
Publish Date: 2022-08-12
Submission Date: 2022-08-17
Documents
Tender Notice